Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Da Qing Offspring Study

NCT06958640 is registered in ClinicalTrials.gov with China-Japan Friendship Hospital as lead sponsor.

NCT NCT06958640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06958640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Da Qing Offspring Study
Lead sponsor
China-Japan Friendship Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
April 1, 2025
Completion date
December 31, 2026
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cardiovascular diseases (cvd), comorbidity, diabetes mellitus, impaired glucose tolerance (prediabetes), inter- and transgenerational inheritance, offspring, adult, prevention